Cargando…

Systematic review of catatonia treatment

OBJECTIVE: To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. MATERIALS AND METHODS: A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelzer, Anne CM, van der Heijden, Frank MMA, den Boer, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775747/
https://www.ncbi.nlm.nih.gov/pubmed/29398916
http://dx.doi.org/10.2147/NDT.S147897
_version_ 1783293976722276352
author Pelzer, Anne CM
van der Heijden, Frank MMA
den Boer, Erik
author_facet Pelzer, Anne CM
van der Heijden, Frank MMA
den Boer, Erik
author_sort Pelzer, Anne CM
collection PubMed
description OBJECTIVE: To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. MATERIALS AND METHODS: A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particular interventions for catatonia and/or catatonic symptoms in adult populations and used valid outcome measures was performed. The articles for this review were selected by searching the electronic databases of the Cochrane Library, MEDLINE, EMBASE and PSYCHINFO. RESULTS: Thirty-one articles met the inclusion criteria. Lorazepam and electroconvulsive therapy (ECT) proved to be the most investigated treatment interventions. The response percentages in Western studies varied between 66% and 100% for studies with lorazepam, while in Asian and Indian studies, they were 0% and 100%. For ECT, the response percentages are 59%–100%. There does not seem to be evidence for the use of antipsychotics in catatonic patients without any underlying psychotic disorder. CONCLUSION: Lorazepam and ECT are effective treatments for which clinical evidence is found in the literature. It is not possible to develop a treatment protocol because the evidence for catatonia management on the basis of the articles reviewed is limited. Stringent treatment studies on catatonia are warranted.
format Online
Article
Text
id pubmed-5775747
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57757472018-02-02 Systematic review of catatonia treatment Pelzer, Anne CM van der Heijden, Frank MMA den Boer, Erik Neuropsychiatr Dis Treat Review OBJECTIVE: To investigate the evidence-based treatment of catatonia in adults. The secondary aim is to develop a treatment protocol. MATERIALS AND METHODS: A systematic review of published treatment articles (case series, cohort or randomized controlled studies) which examined the effects of particular interventions for catatonia and/or catatonic symptoms in adult populations and used valid outcome measures was performed. The articles for this review were selected by searching the electronic databases of the Cochrane Library, MEDLINE, EMBASE and PSYCHINFO. RESULTS: Thirty-one articles met the inclusion criteria. Lorazepam and electroconvulsive therapy (ECT) proved to be the most investigated treatment interventions. The response percentages in Western studies varied between 66% and 100% for studies with lorazepam, while in Asian and Indian studies, they were 0% and 100%. For ECT, the response percentages are 59%–100%. There does not seem to be evidence for the use of antipsychotics in catatonic patients without any underlying psychotic disorder. CONCLUSION: Lorazepam and ECT are effective treatments for which clinical evidence is found in the literature. It is not possible to develop a treatment protocol because the evidence for catatonia management on the basis of the articles reviewed is limited. Stringent treatment studies on catatonia are warranted. Dove Medical Press 2018-01-17 /pmc/articles/PMC5775747/ /pubmed/29398916 http://dx.doi.org/10.2147/NDT.S147897 Text en © 2018 Pelzer et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Pelzer, Anne CM
van der Heijden, Frank MMA
den Boer, Erik
Systematic review of catatonia treatment
title Systematic review of catatonia treatment
title_full Systematic review of catatonia treatment
title_fullStr Systematic review of catatonia treatment
title_full_unstemmed Systematic review of catatonia treatment
title_short Systematic review of catatonia treatment
title_sort systematic review of catatonia treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775747/
https://www.ncbi.nlm.nih.gov/pubmed/29398916
http://dx.doi.org/10.2147/NDT.S147897
work_keys_str_mv AT pelzerannecm systematicreviewofcatatoniatreatment
AT vanderheijdenfrankmma systematicreviewofcatatoniatreatment
AT denboererik systematicreviewofcatatoniatreatment